Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology.
In an industry obsessed with labelling everything and confining it to a certain box, Anodyne 2: Return to Dust feels like a protest. It’s official description lists it as an action-adventure, but it’s ...
Your feet have become your worst enemy — yet another unpleasant reminder that you have diabetes. According to the Food and Drug Administration, up to 62 percent of American diabetics experience the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results